Metraipolis › archive › dc_d68dc0d5b774
Procoagulant Effect of FIX Concentrates and Bypass Agents in Combination with Emicizumab and Impact of FVIII Inhibitors — Europe PMC PMID:42072318
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42072318
- DOI
- 10.3390/biomedicines14040777
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T17:29:34.446Z
- SHA-256 of the archived text
6c19eb7b553ffe89a379288a1196cd1e0ee05edd8be01dc9aafbc5be90045bd1- Stable URL of this page
https://metraipolis.com/documento/dc_d68dc0d5b774
How to cite
Procoagulant Effect of FIX Concentrates and Bypass Agents in Combination with Emicizumab and Impact of FVIII Inhibitors — Europe PMC PMID:42072318 — Europe PMC (en), https://europepmc.org/article/MED/42072318 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d68dc0d5b774 (Metraipolis archive dc_d68dc0d5b774, sha256 6c19eb7b553ffe89a379288a1196cd1e0ee05edd8be01dc9aafbc5be90045bd1)
BibTeX
@misc{dcd68dc0d5b774,
title = {Procoagulant Effect of FIX Concentrates and Bypass Agents in Combination with Emicizumab and Impact of FVIII Inhibitors — Europe PMC PMID:42072318},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42072318},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d68dc0d5b774; sha256 6c19eb7b553ffe89a379288a1196cd1e0ee05edd8be01dc9aafbc5be90045bd1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42072318. Agents can read the archived copy with the MCP tool read_document.